The University of Queensland is a public research university located primarily in Brisbane, the capital city of the Australian state of Queensland. Founded in 1909 by the Queensland parliament, UQ is one of the six sandstone universities, an informal designation of the oldest university in each state. UQ is also a founding member of edX, Australia's leading Group of Eight and the international research-intensive Association of Pacific Rim Universities.
The Queensland University of Technology (QUT) is a public research university located in the coastal city of Brisbane in Queensland, Australia. It has two major campuses, a modern city campus in Gardens Point and a historical campus in Kelvin Grove. The university offers courses in fields including architecture, engineering, information technology, healthcare, teaching, law, arts and design, science and mathematics.
Central Queensland University is an Australian public university based in central Queensland. CQUniversity is the only Australian university with a campus presence in every mainland state. Its main campus is at Norman Gardens in Rockhampton, however, it also has campuses in Adelaide (Wayville), Brisbane, Bundaberg (Branyan), Cairns, Emerald, Gladstone, Mackay, Melbourne, Noosa, Perth, Rockhampton City, Sydney and Townsville. CQUniversity also partners with university centres in several regional areas across Australia.
The QIMR Berghofer Medical Research Institute is an Australian medical research institute located in Herston, Brisbane, in the state of Queensland. QIMR was established in 1945 by the Government of Queensland through the enactment of the Queensland Institute of Medical Research Act 1945 (Qld). Previously known as the Queensland Institute of Medical Research (QIMR), the original purpose of the institute was to further the study of tropical diseases in North Queensland. The current director is Professor Fabienne Mackay. The institute is a registered charity. In 2021, the institute was named as one of the Queensland Greats by the Queensland Government.
Ian Hector Frazer is a Scottish-born Australian immunologist, the founding CEO and Director of Research of the Translational Research Institute (Australia). Frazer and Jian Zhou developed and patented the basic technology behind the HPV vaccine against cervical cancer at the University of Queensland. Researchers at the National Cancer Institute, Georgetown University, and University of Rochester also contributed to the further development of the cervical cancer vaccine in parallel.
The Kolling Institute is located in the grounds of the Royal North Shore Hospital in St Leonards, Sydney Australia. The institute, founded in 1920, is the oldest medical research institute in New South Wales.
The Institute of Health and Biomedical Innovation (IHBI) was an Australian collaborative medical research institute established in 2000 and based at the Queensland University of Technology (QUT) in Brisbane, Queensland. While the bulk of the institute was located at a purpose-built facility on the Kelvin Grove campus of QUT, a number of projects were conducted at sites across the two main QUT campuses and at multi-partner research institutes adjoining major hospitals. Research was also conducted at IHBI's Medical Engineering Research Facility (MERF), in the grounds of the Prince Charles Hospital.
The John Curtin School of Medical Research (JCSMR) is an Australian multidisciplinary translational medical research institute and postgraduate education centre that forms part of the Australian National University (ANU) in Canberra. The school was founded in 1948 as a result of the vision of Nobel Laureate Sir Howard Florey and was named in honour of Australia's World War II Prime Minister John Curtin, who had died in office a few years earlier.
Translational research is research aimed at translating (converting) results in basic research into results that directly benefit humans. The term is used in science and technology, especially in biology and medical science. As such, translational research forms a subset of applied research.
Pamela J. Russell was an Australian academic researcher of immunology, bladder and prostate research. Russell was awarded Membership of the Order of Australia (AM) for her research on prostate and bladder cancer in 2003.
Colleen Nelson is a scientist in prostate cancer research. She founded and directs the Australian Prostate Cancer Research Centre – Queensland (APCRC-Q). The Centre, based at the Translational Research Institute and the Princess Alexandra Hospital, spans the spectrum of discovery of new therapeutic targets and their preclinical and clinical development. She is also Chair of Prostate Cancer Research at Queensland University of Technology (QUT).
Judith Ann Clements is an Australian academic and educator, specializing in Kallikrein proteases in prostate and ovarian cancers. Clements is the scientific director at the Australian Prostate Cancer Research Centre – Queensland and was head of the Cancer Research Program at the Institute of Health and Biomedical Innovation (IHBI) of Queensland University of Technology at the Translational Research Institute (Australia) from 1997–2014.
Glenda Gobe is a molecular biologist specialising in the molecular controls of apoptosis in kidney disease. She is Co-Director of the Centre for Kidney Disease Research (CKDR), School of Medicine, Translational Research Institute and The University of Queensland and Reader in the Discipline of Medicine at the School of Medicine, University of Queensland.
The University of Queensland's Australian Institute for Bioengineering and Nanotechnology (AIBN) was established in 2003. It is one of four stand-alone research institutions at the university with more than 500 researchers, students and support staff. The inaugural Director was Peter Gray. The institute's second director, Professor Alan Rowan, commenced in 2016.
Health Translation Queensland is the first Advanced Health Research Translation Centre in Queensland, Australia.
Peter Bordier Høj is a Danish-Australian academic and Vice-Chancellor and President of the University of Adelaide. Peter Høj is one of the longest serving Australian Vice-Chancellors having served for 16 years across three universities. He has previously served as Vice-Chancellor and President of the University of Queensland and the University of South Australia. Educated at the University of Copenhagen, Høj completed a Bachelor of Science where he majored in biochemistry and chemistry, a Master of Science in biochemistry and genetics and a Doctor of Philosophy in Photosynthesis. He has worked in Denmark and Australia as a researcher and published multiple scientific articles. Høj has also served on a number of different company boards in a variety of roles, including current roles on the boards of CSIRO, Wine Australia and of the Australian Cancer Research Foundation. In 2017 he was elected chair of the Group of Eight, a lobby group that represents Australia’s research-intensive universities. He was the vice-chancellor of the University of Queensland from 2012-2020.
Hudson Institute of Medical Research is a leading Australian medical research institute recognised internationally for discovery science and translational research.
The Queensland Brain Institute (QBI) is an Australian neuroscience research institute, located in Brisbane at the St Lucia campus of The University of Queensland (UQ). Founding director Professor Perry Bartlett established the QBI in 2003 with assistance from The University of Queensland, Queensland State Government, and Chuck Feeney, founder of The Atlantic Philanthropies. The purpose-built facility was commissioned in 2004 and on 19 November 2007, the building was opened by former Queensland Premier Anna Bligh.
Professor David Wayne Johnson is an Australian nephrologist known for kidney treatments and transplants in Australia. In 2009 he was a Queensland State Finalist for Australian of the Year, for his work in the early recognition and care of people with chronic kidney disease and specifically for his work in detection of chronic kidney disease.
Professor Wendy Elizabeth Hoy AO is a Fellow of the Australian Academy of Science (FAA), the Director of the Centre for Chronic Disease at the University of Queensland, Australia, and was appointed an Officer of the Order of Australia (AO) in 2010 and elected as a member of the Australian Academy of Science in 2015. Hoy's research has involved developing new types of kidney imaging and improving health and lives for indigenous populations, in Australia, Sri Lanka and the USA.
